Staterra Multi-Nutrient
Natural health product licensed in Canada
- Licence holder
- Staterra Inc.
- NPN or DIN-HM
- 80079453
- Status
- Active licence
- Licence date
- 15 August 2017
- Revision date
- 11 April 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine K2 Source : Ménaquinone 7 | 5 microgrammes | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 7.5 milligramme | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 7.5 milligramme | 30,000 µg |
| Fer Source : Diglycinate de fer (II) | 1.25 milligramme | 5,000 µg |
| Potassium Source : Citrate de potassium | 12.5 milligramme | 50,000 µg |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Microorganismes CoQ10 - Cellule entière pour biosynthèse | 12.5 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of vitamins and minerals to support biological functions which play a key role in the maintenance of good health. A source of antioxidants for the maintenance of good health. Helps in energy metabolism and tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are taking blood thinners, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If you are pregnant or breastfeeding, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking blood pressure medication.
- Effets indésirables connus
Hypersensitivity has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80079453
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging